
AstraZeneca Covid-19 vaccine: How common are blood clots and should I be worried?
CNN
Following weeks of speculation about whether Oxford-AstraZeneca's Covid-19 vaccine might be connected to dozens of cases of blood clots reported in the region, European drug regulators have now announced that there is a possible link.
The European Medicines Agency (EMA) stopped short of changing its guidance on how the vaccine is used, maintaining that the overall benefits still outweigh the risks, while some European countries are restricting use of the shot to older age groups only. On the same day, UK authorities also confirmed the link and emphasized that the benefits of the AstraZeneca shot outweighed its risk overall, but took a different course of action for people under the age of 30, advising that they are given different vaccines, if available.More Related News